For the first time, scientists from the Centre for Addiction and Mental Health (CAMH) have discovered epigenetic changes (chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. The findings may be a significant step on the way to fully understanding major psychosis.
CAMH’s Dr. Arturas Petronis studied 12,000 locations on the genome using an epigenomic profiling technology and found that approximately one in every two hundred of these genes showed an epigenetic difference in the brains of psychiatric patients. Significantly, these changes were noted on genes involved in neurotransmission (the exchange of chemical messages within the brain) and brain development.
The new work is the first demonstration of what CAMH epigeneticists have hypothesized for the last 10 years. “Until now, we only had theories that epigenetic changes were important to understanding what causes major psychosis,” said Petronis. “Now we have the tools and expertise to support our theories and we can look at conducting larger studies, which will hopefully give us an even better understanding of psychiatric illnesses.”